Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Ionis Pharmaceuticals, Inc. (IONS) had Weighted-Average Shares Outstanding (Diluted) of 164.87M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$246.09M |
|
$-92.53M |
|
$2.98M |
|
$243.11M |
|
$363.51M |
|
$-117.42M |
|
$25.11M |
|
$-92.31M |
|
$-114.89M |
|
$-92.53M |
|
$-92.53M |
|
$-92.53M |
|
$-115.06M |
|
$-117.42M |
|
$-113.82M |
|
164.87M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
164.87M |
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$2.94B |
|
$142.40M |
|
$513.02M |
|
$3.45B |
|
$716.59M |
|
$1.35B |
|
$2.24B |
|
$2.96B |
|
$491.41M |
|
$491.41M |
|
$491.41M |
|
165.90M |
|
| Cash Flow Statement Financials | |
$-792.82M |
|
$536.82M |
|
$57.26M |
|
$372.26M |
|
$173.38M |
|
$-198.88M |
|
$43.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.10 |
|
-- |
|
-- |
|
0.73 |
|
3.63 |
|
98.79% |
|
-47.72% |
|
-47.72% |
|
-- |
|
-37.51% |
|
-37.60% |
|
$-814.58M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.54 |
|
3.34 |
|
26.95 |
|
-18.83% |
|
-18.83% |
|
-2.68% |
|
-5.03% |
|
$2.96 |
|
$-4.94 |
|
$-4.81 |
|